Search

everythinglearnresearchcommunity

for

Search:↓

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.

Men with Kennedy disease have less chance of hair loss.

A woman had skin and hair issues after a botulinum toxin injection.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Common cosmetic dermatology techniques improve skin damaged by the sun and aging.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Low-level laser therapy may help stem cells grow and function better, aiding in healing and tissue repair.

A patient with Myotonic dystrophy type 1 had multiple tongue hemangiomas and was sensitive to anesthesia.

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Human hair loss may have evolved to help increase brain size.